— Know what they know.
Not Investment Advice

BLMS OTC

Bloomios, Inc.
1W: +0.0% 1M: +0.0% 3M: +200.0% YTD: +200.0% 1Y: +200.0% 3Y: -100.0% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Neutral · Power 49 · $19341 mcap · 42M float · 0.0000% daily turnover

Supply Chain Overview

1 relationships
0
As Filer
counterparties named
1
As Counterparty
mentioned by others
2022-11-01
Earliest Filing
2022-11-01
Latest Filing

Mentioned As Counterparty

1 mentions

Other companies that named BLMS in their SEC 8-K filings.

Filed By Relationship Summary Filing Date SEC
UPXI UPEXI, INC. target Bought 100% of Infusionz LLC from Upexi, Inc. for $23.5M in cash, convertible notes, preferred stock, debentures, and wa 2022-11-01 View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms